A Phase 3, Randomized Study of SU011248 versus Interferon-a as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma

Mise à jour : Il y a 4 ans
Référence : EUCTR2004-001149-14

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To compare the time to tumor progression (TTP) associated with SU011248 versus that associated with IFN-a for the first-line treatment of patients with metastatic renal cell carcinoma


Critère d'inclusion

  • Histologically confirmed renal cell carcinoma with metastases with a component of clear (conventional) cell histology